|本期目录/Table of Contents|

[1]申永存,徐维赟.1S二苯基膦2R二(3,5二甲基苯基)膦二茂铁的合成[J].武汉工程大学学报,2010,(05):22-24.[doi:10.3969/j.issn.16742869.2010.05.006]
 SHEN Yong cun,XU Wei yun.Synthesis of (R)1[(S)2(Diphenylphosphino)ferrocenyl]ethyldi3,5xylylphosphine[J].Journal of Wuhan Institute of Technology,2010,(05):22-24.[doi:10.3969/j.issn.16742869.2010.05.006]
点击复制

1S二苯基膦2R二(3,5二甲基苯基)膦二茂铁的合成
(/HTML)
分享到:

《武汉工程大学学报》[ISSN:1674-2869/CN:42-1779/TQ]

卷:
期数:
2010年05期
页码:
22-24
栏目:
化学与化学工程
出版日期:
2010-05-31

文章信息/Info

Title:
Synthesis of (R)1[(S)2(Diphenylphosphino)
ferrocenyl]ethyldi3,5xylylphosphine
文章编号:
16742869(2010)05002203
作者:
申永存徐维赟
武汉理工大学化学工程学院制药工程系,湖北 武汉 430070
Author(s):
SHEN YongcunXU Weiyun
Department of Pharmaceutical Engineering,Wuhan University of Technology,Wuhan 430070,China
关键词:
1S二苯基膦2R二(35二甲基苯基)膦二茂铁手性二茂铁类双膦配体合成
Keywords:
(R)1[(S)2(Diphenylphosphino)ferrocenyl]ethyldi35xylylphosphine chiral ferrocenyldiphosphine ligands synthesis
分类号:
TQ460.31
DOI:
10.3969/j.issn.16742869.2010.05.006
文献标志码:
A
摘要:
以廉价的二茂铁为原料经付克酰化、还原、酯化、胺解、拆分等反应得RN,N二甲基胺乙基二茂铁,经锂化等多步反应得到高立体选择性的1S二苯基膦2R二(3,5二甲基苯基)膦二茂铁.整个反应过程操作简单,收率达14.6%.产品结构经氢谱、碳谱、磷谱确证.研究结果表明:该路线可行,能够满足工业化大生产的要求.
Abstract:
The cheap ferrocene was used as the starting material to synthesize (R)N,NDimethyl1ferrocenylethylamine by FC acylation, reduction, esterification, amination and resolution. (S)1N,Ndimethyl[2(R)(diphenylphosphino)ferrocenyl]ethylamine was obtained by high enantioselectve reaction of (R)N,NDimethyl1ferrocenylethylamine and Ph2Cl, then the target compound (R)1[(S)2(diphenylphosphino)ferrocenyl]ethyldi3,5xylylphosphine was manufacturated by substitution of Xyl2PH and (S)1N,Ndimethyl[2(R)(diphenylphosphino)ferrocenyl]ethylamine. The total yield was 14.6% and its purity was 97%. The structure was confirmed by 1HNMR, 13CNMR, 31PNMR. The results showed that the route is feasible, the operation is simple, safe, and yield of the product is higher.The synthesis route could meet the demands of large industrial production.

参考文献/References:

[1]宋庆宝,东宇.二茂铁手性膦配体研究的一些进展[J].有机化学,2007,27(1):6671.
[2]Arrayas R G, Adrio J, Carretero J C. Recent Applications of Chiral Ferrocene Ligands in Asymmetric Catalysis[J]. Angew Chem Int Ed,2006,45(46):76747715.
[3]Manuel A F, Shen Q L, Hartwig J F. Highly Efficient and Functional Group Tolerant Catalysts for the PalladiumCatalyzed Coupling of Aryl Chlorides with Thiols[J].Chem Eur J,2006,12(30):77827796.
[4]Colacot T J. A Concise Update on the Applications of Chiral Ferrocenyl Phosphines in Homogeneous Catalysis Leading to Organic Synthesis[J].Chem Rev,2003,103(8):31013118.
[5]Feng X D, Pugin B, Blaser H U,et al. Josiphos Ligands with an Imidazolium Tag and their Application for the Enantioselective Hydrogenation in Ionic Liquids[J]. Adv Synth Catal,2007,349(10):18031807.
[6]Hayashi T, Mise T, Yamamoto K. Asymmetric Synthesis Catalyzed by Chiral FerrocenylphosphineTransition Metal Complexes. I. Preparation of Chiral Ferrocenylphosphines[J]. Bull Chem Soc Jpn,1980,53(4):11521156.
[7]Dorta R, Broggini D, Stoop R. Chiral Xyliphos Complexes for the Catalytic Imine Hydrogenation Leading to the Metolachlor Herbicid:Isolation of Catalyst Substrate Adducts[J]. Chem Eur J,2004,10(1):267278.
[8]Togni A, Breutel C Schnyder A, A Novel Easily Accessible Chiral Ferrocenyldiphosphine for Highly Enantioselective Hydrogenation, Allylic Alkylation, and Hydroboration Reactions.[J].J Am Chem Soc,1994,116(9):40624066.
[9]Tappe K, Knochel P. New Efficient Synthesis of Taniaphos Ligands: Application in Rutheniumand RhodiumCatalyzed Enantioselective Hydrogenations.[J].Tetrahedron:Asymmetry,2004,15(1):91102.
[10]Marquarding D, Klusacek H, George G, et al. Correlation of Central and Planar Chirality in Ferrocene Derivatives [J].J Am Chem Soc,1970,92(8):53895393.
[11]Blaser H U, Brieden W, Pugin B, et al. Solvias Josiphos Ligands: from Discovery to Technical Applications[J]. Topics in Catalysis,2002,19(1):316.

相似文献/References:

备注/Memo

备注/Memo:
收稿日期:20090622作者简介:申永存(1966),男,湖北武汉人,教授,博士,硕士研究生导师.研究方向:新药的合成与筛选、不对称合成、抗病毒药物的合成及工艺研究.
更新日期/Last Update: